December 2, 2022
On Tuesday, November 29, the Overdose Prevention Initiative at the Global Health Advocacy Incubator joined nearly 200 organizations to issue a letter urging Congress to pass the bipartisan Mainstreaming Addiction Treatment (MAT) Act by the end of the year. If passed, the MAT Act would prevent overdoses, increase access to treatment, and reduce stigma by removing federal rules that prevent healthcare providers from prescribing a lifesaving medication for opioid use disorder.
The U.S. House of Representatives passed the MAT Act in June as part of the Restoring Hope for Mental Health and Well-Being Act of 2022. The package passed with near-unanimous bipartisan support (402-20).
Since 1997, the United States has lost more than one million people to drug overdoses. More than 108,000 of those deaths occurred in 2021 alone. If nothing changes, we are projected to lose one million more people to drug overdose by 2030. Each person lost to the U.S. overdose crisis leaves behind children without a parent, lost siblings, friends, and communities.
Overdose deaths are preventable through evidence-based treatment, including medications for opioid use disorder that prevent withdrawal symptoms and stem cravings. By passing the MAT Act, Congress can prevent future deaths and help people with substance use disorder secure recovery.
You can find a link to the letter here.
Established in 2021, the Overdose Prevention Initiative at the Global Health Advocacy Incubator advances policy solutions that save lives and end the U.S. overdose crisis. The Initiative is dedicated to reducing inequities and disparities in substance use disorder care and expanding access to harm reduction services and substance use disorder treatment.
The Overdose Prevention Initiative is funded by Bloomberg Philanthropies and is a partnership between the Global Health Advocacy Incubator and the Tobacco Free Kids Action Fund.
For questions, please contact Ben Orton-Vipond at email@example.com.